At the time of diagnosis and treatment of the primary eye tumor did the patient utilize support services? How did this vary by country and region of residence? 117 responses I. The Patient Journey Personal Profile/Primary Diagnosis
The 13% of patients who responded “Yes” reported:
Country of residence:
7% Australia
7% Canada
(1 response)
(1 response)
3% Unknown
86% United States (11 responses)
The 3% of patients who responded “Unknown” reported:
US region:
73% West
9% Southeast (1 response) 9% Northeast (1 response)
100% United States (4 responses) Country of residence:
(8 responses)
9% Midwest
13% Yes
(1 response)
US region:
The 52% of patients who responded “No” reported:
50% Midwest
25% Northeast (1 response)
52% No
(2 responses)
Country of residence:
25% Southeast (1 response)
6% Australia
(4 responses) Ireland (1 response) Mexico (1 response) New Zealand (1 response) Norway (1 response)
32% Not offered
The 32% of patients who responded “Not offered” reported:
2%
2%
Country of residence:
Canada (4 responses)
Slovenia (1 response)
11%
3%
2%
86% United States (32 responses)
2%
US region:
86% United States (53 responses)
25% Southeast
28% West
(8 responses)
(9 responses) Southwest (2 responses) Midwest (3 responses)
US region:
32% Northeast
6%
21% West
17% Midwest
21% Northeast
(10 responses)
(11 responses)
(9 responses)
(11 responses)
9%
13% Southwest
28% Southeast
(7 responses)
(15 responses)
2023 VISION Registry Data Report
21
Made with FlippingBook Ebook Creator